Drug Discovery

How Will Ono's $2.4 Billion Buyout of Deciphera Transform Pharma?
Research & Development How Will Ono's $2.4 Billion Buyout of Deciphera Transform Pharma?

In a bold move that underscores the dynamism of the pharmaceutical industry, Ono Pharmaceutical Co., Ltd. has executed a major acquisition of Deciphera Pharmaceuticals Inc. The deal, valued at a hefty $2.4 billion, positions Ono strategically as a more influential player on the global stage,

How Did the FDA Shape Drug Approvals in 2023-2024?
Research & Development How Did the FDA Shape Drug Approvals in 2023-2024?

Throughout 2023 and 2024, the U.S. Food and Drug Administration (FDA) played a pivotal role in the pharmaceutical and biotechnology sectors, not only by approving a significant number of new drugs but also by pushing the boundaries of innovation. These two years were marked by a notable surge in

How Is CPL Transforming Pharma with New Ownership & Innovation?
Research & Development How Is CPL Transforming Pharma with New Ownership & Innovation?

The pharmaceutical landscape is witnessing a dynamic shift as companies like Contract Pharmaceuticals Limited (CPL) embrace new ownership structures aimed at invigorating their strategic direction. When a company of CPL's stature undergoes significant change, it signals to the industry

How Will AI Revolutionize Drug Discovery for Hoth Therapeutics?
Research & Development How Will AI Revolutionize Drug Discovery for Hoth Therapeutics?

In the fast-evolving landscape of biopharmaceuticals, innovative approaches to drug discovery signal a transformative era for companies like Hoth Therapeutics Inc. A strategic partnership with Wise Systems International SRL marks the beginning of an ambitious journey to incorporate artificial

How Will Peptide Backbone Tweaks Revolutionize Drug Discovery?
Research & Development How Will Peptide Backbone Tweaks Revolutionize Drug Discovery?

Despite tremendous advancements in medical science, drug discovery remains a daunting challenge, particularly when it comes to illnesses involving complex protein interactions. Conventional drug development strategies fall short when faced with the vast network of protein-protein interactions

Tetra Pharm and Kvantify Partner to Innovate ECS Drug Discovery
Research & Development Tetra Pharm and Kvantify Partner to Innovate ECS Drug Discovery

The partnership between Tetra Pharm Technologies and Kvantify signifies a major step forward in the realm of drug discovery, particularly within the arena of the endocannabinoid system (ECS). This alliance is poised to not only speed up the discovery process but also holds the promise of yielding

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later